Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Ticker
SHPH
Exchange
Nasdaq
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Market cap
$4.31M
52-week range
$2.58 - $44.40

Valuation

Share price
$3.82 (close of Nov 18, 2026)
P/E (TTM)
-0.16x
Price to book
0.22x
Price to free cash flow
-0.65x
Enterprise value
$4.41M
Book value per share
$19.16

Price performance

PeriodChange
1 day-11.16%
5 days-27.24%
1 month-24.80%
3 months-2.55%
6 months-38.39%
Year to date-78.78%
1 year-81.90%
3 years-99.61%
All time-100.00%

Short interest

As of
Oct 30, 2026
Short % of float
0.31%
Shares short
14.96K
Days to cover
0.54
Change since prior report
-52.23%
Source
FINRA consolidated short interest

Profitability and growth

Return on assets
-111.89%

Cash flow and balance sheet

Free cash flow yield (TTM)
-152.95%
Current ratio
0.11x
Net debt to EBITDA
-0.01x

Latest reported year

Period end
Dec 31, 2025
Fiscal year
2025
EBITDA
-$11.63M
Net income
-$11.72M
Research and development
$4.05M

Income statement by year

Period endNet income
2025-12-31-$11.72M
2024-12-31-$9.14M
2023-12-31-$6.59M
2022-12-31-$5.00M
2021-12-31-$1.15M

Margins and returns by year

Period endReturn on equityReturn on capital
2023-12-31-162.55%-114.56%
2022-12-31-65.07%-27.82%

Cash and debt by year

Period endCashDebt
2025-12-31$334.00K-
2024-12-31$1.92M-
2023-12-31$2.58M$135.09K
2022-12-31$8.42M-
2021-12-31$504.75K$91.02K
2020-12-31$117.15K-
2018-12-31$352.39K-
2017-12-31$50.71K-

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-12-31-$9.48M$932.97K
2024-12-31-$7.33M$259.74K
2023-12-31-$5.60M$181.96K
2022-12-31-$2.67M$237.55K
2021-12-31-$300.34K$910.07K
2020-12-31-$37.65K$459.59K
2018-12-31-$566.69K-
2017-12-31-$202.71K-

Investor relations

Next earnings report

Next confirmed report
Nov 19, 2026

Past earnings dates

ReportedFiscal periodEPS estimate
2026-11-12Sep 2026-
2026-09-24Jun 2026-
2026-05-15Mar 2026-
2025-11-13Sep 2025-
2025-08-12Jun 2025-
2025-05-08Mar 2025-
2024-11-13Sep 2024-
2024-09-03Jun 2024-

Filings and sources

Company website
shuttlepharma.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Teva Pharmaceutical Industries Ltd (TEVA) · Zoetis Inc. (ZTS) · Viatris Inc (VTRS) · Hims & Hers Health, Inc. (HIMS) · Haleon plc (HLN) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades